Vinco's twist on non-fungible tokens is a three-dimensional NFT that brings entertainers and athletes into your living room via virtual and augmented reality.
Plus, the Senate passes a big, fat bill to promote the nation's ability to compete on the technology innovation front.
Plus, it appears there may be headway on an infrastructure bill that could work for both sides of the aisle.
Growth stocks and speculative small caps have perked up nicely.
There's a merger involving one company, a collaborative agreement for another and hints of a positive regulatory development for a third.
Let's look at seven names that you can buy right now and watch grow.
Dealmaking is going strong and looks set to continue as mental health becomes a key investment theme going forward.
Copper and gold producer Freeport-McMoRan serves an example of a dull but cheap stock that is finding investor favor again.
Mydecine Innovations Group -- formerly known as NewLeaf -- signed an agreement with the University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences.
Tivity Health's big price drop serves as an example of the thought process an investor must go through when a holding takes an unexpected hit.